Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
AvenCell Therapeutics’ $112 Million Series B Funding Round
Charlesbank Capital Partners’ Investment in Salus GRC
Ropes & Gray advised Charlesbank Capital Partners and Salus GRC on the deal. Charlesbank Capital Partners (“Charlesbank”) announced that it has entered into a partnership with...